Amend 012 - PERTUSSIS VACCINES - GlaxoSmithKline Inc.
Status Expired
Contract number E60PH-21PERT/002/PH
Amendment value :
Solicitation number E60PH-21PERT
Publication date
Contract award date
Last amendment date
Status Expired
Contract number E60PH-21PERT/002/PH
Amendment value :
Solicitation number E60PH-21PERT
Publication date
Contract award date
Last amendment date
The contract will be for a period of 62 month(s), from 2021/01/05 to 2026/03/31.
CAD 69,727,409.40
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below: